Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Last Andrew J. | EVP, Chief Operating Officer | Apr 29 | Option Exercise | 0.00 | 1,000 | 0 | 2,764 | May 02 02:44 PM | RAMALINGAM AJIT | SVP, Chief Accounting Officer | Apr 29 | Option Exercise | 0.00 | 277 | 0 | 698 | May 02 02:42 PM | Daskal Ilan | EVP, Chief Financial Officer | Apr 08 | Option Exercise | 0.00 | 700 | 0 | 709 | Apr 11 12:16 PM | WRIGHT DARA | Executive Vice President | Dec 16 | Option Exercise | 0.00 | 502 | 0 | 1,113 | Dec 17 02:21 PM | TUMOLO ANNETTE | Executive Vice President | Nov 12 | Option Exercise | 250.21 | 4,800 | 1,201,014 | 9,393 | Nov 15 10:55 AM | TUMOLO ANNETTE | Executive Vice President | Nov 12 | Sale | 750.05 | 4,800 | 3,600,240 | 4,593 | Nov 15 10:55 AM | TUMOLO ANNETTE | Executive Vice President | Nov 11 | Option Exercise | 386.82 | 1,546 | 598,029 | 6,139 | Nov 15 10:55 AM | TUMOLO ANNETTE | Executive Vice President | Nov 11 | Sale | 749.00 | 1,546 | 1,157,958 | 4,593 | Nov 15 10:55 AM | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sep 07 | Option Exercise | 92.56 | 40,000 | 3,702,220 | 336,786 | Sep 09 09:39 AM | Crowley Michael | EVP, GBL Commercial Operations | Sep 07 | Option Exercise | 0.00 | 600 | 0 | 5,371 | Sep 09 09:38 AM | TUMOLO ANNETTE | Executive Vice President | Sep 07 | Option Exercise | 0.00 | 600 | 0 | 4,891 | Sep 09 09:38 AM | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sep 07 | Option Exercise | 0.00 | 500 | 0 | 2,401 | Sep 09 09:37 AM | Crowley Michael | EVP, GBL Commercial Operations | Sep 05 | Option Exercise | 0.00 | 600 | 0 | 5,069 | Sep 08 12:10 PM | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sep 05 | Option Exercise | 0.00 | 2,600 | 0 | 424,960 | Sep 08 12:09 PM | TUMOLO ANNETTE | Executive Vice President | Sep 05 | Option Exercise | 0.00 | 600 | 0 | 4,589 | Sep 08 12:06 PM | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sep 05 | Option Exercise | 0.00 | 500 | 0 | 2,149 | Sep 08 12:05 PM | Crowley Michael | EVP, GBL Commercial Operations | Sep 04 | Option Exercise | 0.00 | 600 | 0 | 4,767 | Sep 08 12:10 PM | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sep 04 | Option Exercise | 0.00 | 2,600 | 0 | 423,650 | Sep 08 12:09 PM | TUMOLO ANNETTE | Executive Vice President | Sep 04 | Option Exercise | 0.00 | 600 | 0 | 4,287 | Sep 08 12:06 PM | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sep 04 | Option Exercise | 0.00 | 500 | 0 | 1,897 | Sep 08 12:05 PM | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sep 03 | Option Exercise | 0.00 | 464 | 0 | 1,619 | Sep 08 12:05 PM | Crowley Michael | EVP, GBL Commercial Operations | Sep 03 | Option Exercise | 0.00 | 557 | 0 | 4,444 | Sep 08 12:10 PM | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sep 03 | Option Exercise | 0.00 | 2,319 | 0 | 422,200 | Sep 08 12:09 PM | TUMOLO ANNETTE | Executive Vice President | Sep 03 | Option Exercise | 0.00 | 557 | 0 | 3,939 | Sep 08 12:06 PM | Daskal Ilan | EVP, Chief Financial Officer | Sep 03 | Sale | 820.06 | 270 | 221,416 | 9 | Sep 08 12:07 PM | Daskal Ilan | EVP, Chief Financial Officer | Sep 02 | Option Exercise | 261.91 | 1,081 | 283,122 | 548 | Sep 03 05:02 PM | ERNST TIMOTHY S | EVP, General Counsel & Sec | Sep 02 | Option Exercise | 0.00 | 361 | 0 | 1,280 | Sep 03 05:01 PM | SCHWARTZ NORMAN D | Chairman, President, and CEO | Sep 02 | Option Exercise | 0.00 | 1,805 | 0 | 420,776 | Sep 03 05:12 PM | TUMOLO ANNETTE | Executive Vice President | Sep 02 | Option Exercise | 0.00 | 433 | 0 | 3,532 | Sep 03 05:10 PM | Crowley Michael | EVP, GBL Commercial Operations | Sep 02 | Option Exercise | 0.00 | 433 | 0 | 4,102 | Sep 03 05:09 PM | RAMALINGAM AJIT | SVP, Chief Accounting Officer | Sep 02 | Option Exercise | 0.00 | 240 | 0 | 473 | Sep 03 05:07 PM | WRIGHT DARA | Executive Vice President | Sep 02 | Option Exercise | 0.00 | 433 | 0 | 761 | Sep 03 05:08 PM | Last Andrew J. | EVP, Chief Operating Officer | Sep 02 | Option Exercise | 0.00 | 902 | 0 | 2,184 | Sep 03 05:05 PM | Daskal Ilan | EVP, Chief Financial Officer | Sep 02 | Sale | 828.00 | 540 | 447,121 | 7 | Sep 03 05:02 PM | Last Andrew J. | EVP, Chief Operating Officer | Sep 01 | Option Exercise | 299.24 | 2,000 | 598,480 | 3,282 | Sep 03 05:05 PM | Last Andrew J. | EVP, Chief Operating Officer | Sep 01 | Sale | 813.10 | 2,000 | 1,626,203 | 1,282 | Sep 03 05:05 PM | TUMOLO ANNETTE | Executive Vice President | Aug 26 | Sale | 792.58 | 600 | 475,548 | 3,099 | Aug 27 10:39 AM | Crowley Michael | EVP, GBL Commercial Operations | Aug 09 | Option Exercise | 139.56 | 3,000 | 418,680 | 6,669 | Aug 10 11:58 AM | Crowley Michael | EVP, GBL Commercial Operations | Aug 09 | Sale | 754.93 | 3,000 | 2,264,796 | 3,669 | Aug 10 11:58 AM | Daskal Ilan | EVP, Chief Financial Officer | Aug 04 | Option Exercise | 309.84 | 1,400 | 433,776 | 2,307 | Aug 05 12:38 PM | ERNST TIMOTHY S | EVP, General Counsel & Sec | Aug 04 | Sale | 760.26 | 327 | 248,605 | 919 | Aug 05 12:40 PM | Daskal Ilan | EVP, Chief Financial Officer | Aug 04 | Sale | 751.84 | 2,300 | 1,729,241 | 7 | Aug 05 12:38 PM |
|